Jonathan Sporn, Sisi Li, Graham Pechenik, Retsina Meyer, Anne Donohoe
As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.
Hardman provides a quick overview of the emerging psychedelic sector, covering financial, research, and policy landscapes with data visuals. He also explores unanswered questions about the sector's future.
Josh Hardman
Elliot Cohen (Pillpack, Amazon) and Protik Basu (World Bank, UN, Helena) share insights on healthcare delivery, psychedelics industry, scaling challenges, and technology's role in patient care.
Andrew “Mo” Septimus, Protik Basu, Elliot Cohen
Panel on regulatory obstacles in psychedelic therapy research: Leaders from the industry discuss challenges with policymakers and predict future developments in the field.
Tadeusz Hawrot, Natasia Poinsatte, Nicole Howell
Discussion between experts on pragmatic frameworks, demographic considerations, and evidence-based practices shaping psychedelic policy reform for diverse contexts, addressing regulatory challenges and fostering nuanced understanding.
Tatiana Quintana, Melissa Lavasani, Logan Davidson
Professor Rachelle Sampson and collaborators explore how personal transformative experiences, particularly psychedelic ones, can shape a new form of leadership called emergent leadership that fosters collective intelligence for societal problem-solving.
Bennet A Zelner
Drs. Summergrad and Insel reflect on the progress and remaining questions in psychedelic science since 2017. They delve into topics like efficacy, regulation, therapy, and provider experience.
Paul Summergrad, Tom Insel, Rachel Nuwer
Michael Pollan, an influential author, sparked interest in psychedelic research with his book "How to Change Your Mind." Bob Jesse, a key figure in the resurgence of psychedelics, has made
Robert Jesse, Michael Pollan
Carl Hart, Chair of Psychology at Columbia University, is a renowned neuropsychopharmacologist, author, and media personality known for challenging drug perceptions through research, books, and media appearances.
Carl Hart
Funding for psychedelic medicine is evolving, with a rise in commercial capital alongside philanthropic support. Balancing financial interests with equitable access and learning from scaling challenges are key considerations.
Henry Elkus
© 1986 – 2025 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Mailing: MAPS P.O. Box 103004 Pasadena, CA 91189-3004.